Monthly Archive: November 2015

Nov 26

Practical, day-to-day obstacles, including the weather, transportation problems, or finances,

Practical, day-to-day obstacles, including the weather, transportation problems, or finances, can play a major role in decreasing participation in an exercise program for patients with heart failure (HF), which may subsequently result in worsening cardiac outcomes, suggests new research published online in Circulation: Heart Failure.

Nov 25

In women with gestational diabetes mellitus (GDM)

In women with gestational diabetes mellitus (GDM), breastfeeding reduced the risk of progressing to type 2 diabetes, reported a large prospective cohort study published in Annals of Internal Medicine

Nov 19

People who drink up to five cups of coffee per day are less likely to die from heart disease

People who drink up to five cups of coffee per day are less likely to die from heart disease, neurological disease, type 2 diabetes, or suicide, suggested a new study published online November 16 in Circulation.

Nov 19

All iron intravenous (IV) products are associated with anaphylaxis risk, but the risk with iron dextran is significantly higher than with other formulations

All iron intravenous (IV) products are associated with anaphylaxis risk, but the risk with iron dextran is significantly higher than with other formulations, and the risk is lowest with iron sucrose, reported a study of nearly 700,000 Medicare nondialysis patients, published in the November 17 issue of JAMA.

Nov 18

Women with knee pain had a significantly increased risk of all-cause and cardiovascular disease mortality

Women with knee pain had a significantly increased risk of all-cause and cardiovascular disease mortality, with or without radiographic osteoarthritis (ROA), but not with ROA alone, suggested new research published in the Annals of the Rheumatic Diseases.

Nov 18

New findings, presented at the American Heart Association (AHA)

New findings, presented at the American Heart Association (AHA) 2015 Scientific Sessions, suggest that patients with type 2 diabetes and established CVD who received the antidiabetic sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin, had a reduced risk of being hospitalized for heart failure or dying from CVD during a median follow-up of 3.1 years, even if …

Continue reading »

Nov 17

Macrolide antibiotic use is associated with a 2.42-fold increased risk of sudden cardiac death and ventricular tachyarrhythmias

Macrolide antibiotic use is associated with a 2.42-fold increased risk of sudden cardiac death and ventricular tachyarrhythmias, suggests new research published online in the Journal of the American College of Cardiology.

Nov 16

Diabetic patients undergoing revascularization for multivessel coronary disease have a lower risk of death, heart attack

Diabetic patients undergoing revascularization for multivessel coronary disease have a lower risk of death, heart attack, and serious complications if they receive CABG instead of PCI, especially if the setting is stabilized acute coronary syndrome, suggests Canadian registry data presented this week here at the American Heart Association (AHA) 2015 Scientific Sessions.

Nov 16

A high body mass index (BMI) is linked to longer survival terms for several chronic serious diseases; however

A high body mass index (BMI) is linked to longer survival terms for several chronic serious diseases; however, a large European epidemiological study has shown that the protective effect is not applicable to all patients with a high BMI. The findings, published in the Journal of the American Society of Nephrology, indicate that chronic inflammation …

Continue reading »

Nov 14

Six months of aerobic exercise led to increased blood flow in the brain and reduced levels of phosphorylated tau protein levels in cerebrospinal fluid (CSF)

Six months of aerobic exercise led to increased blood flow in the brain and reduced levels of phosphorylated tau protein levels in cerebrospinal fluid (CSF) in adults with mild cognitive impairment (MCI) and prediabetes, according to findings presented at the 8th Clinical Trials Conference on Alzheimer’s Disease.

Older posts «